| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 13 |
| 1 | INFLIXIMAB | 8 |
| 2 | USTEKINUMAB | 8 |
| 3 | AZATHIOPRINE | 7 |
| 4 | ADALIMUMAB-AATY | 6 |
| 5 | ADALIMUMAB-ADAZ | 6 |
| 6 | ADALIMUMAB-FKJP | 6 |
| 7 | MERCAPTOPURINE | 6 |
| 8 | SULFASALAZINE | 6 |
| 9 | CERTOLIZUMAB PEGOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PURIXAN | 1 | 0.0013 |
| 1 | MERCAPTOPURINE | 6 | 0.0003 |
| 2 | ADALIMUMAB-FKJP | 6 | 0.0001 |
| 3 | ADALIMUMAB-AATY | 6 | 0.0001 |
| 4 | ADALIMUMAB-ADAZ | 6 | 0.0001 |
| 5 | SULFASALAZINE | 6 | 0.0001 |
| 6 | AZATHIOPRINE | 7 | 0.0001 |
| 7 | USTEKINUMAB | 8 | 0.0001 |
| 8 | INFLIXIMAB | 8 | 0.0000 |
| 9 | METRONIDAZOLE TOPICAL | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 1 | Interleukin-12 Antagonist [EPC] | 8 |
| 2 | Interleukin-23 Antagonist [EPC] | 8 |
| 3 | Purine Antimetabolite [EPC] | 7 |
| 4 | Aminosalicylate [EPC] | 6 |
| 5 | Integrin Receptor Antagonist [EPC] | 1 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 1 |
| 7 | Retinoid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-12 Antagonist [EPC] | 8 | 0.0001 |
| 1 | Interleukin-23 Antagonist [EPC] | 8 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 3 | Aminosalicylate [EPC] | 6 | 0.0001 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 5 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 9 | 0.0000 |
| 7 | Retinoid [EPC] | 1 | 0.0000 |